CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2019; 38(02): 128-136
DOI: 10.1055/s-0039-1685150
Case Report | Relato de Caso
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Oligodendroglioma with Sarcomatous Transformation: Case Report and Literature Review

Oligodendroglioma com transformação sarcomatosa: Caso clínico e revisão da literatura
1   Department of Neurosurgery, Centro Hospitalar do Porto, Porto, Portugal
,
Célia Maria Pinheiro
1   Department of Neurosurgery, Centro Hospitalar do Porto, Porto, Portugal
,
Alfredo Luís Calheiros
1   Department of Neurosurgery, Centro Hospitalar do Porto, Porto, Portugal
› Author Affiliations
Further Information

Publication History

23 October 2018

19 February 2019

Publication Date:
18 April 2019 (online)

Abstract

Oligodendrogliomas are infiltrative tumors of the central nervous system considered to be morphologically stable and to offer a better prognosis. Here, we describe the case of a 36-year-old man with an initial diagnosis of oligodendroglioma, World Health Organization (WHO) grade II, who presented transformation to a sarcomatous form, while maintaining the oligodendroglial component as well as the genetic characteristics of the initial tumor without having undergone any complementary treatments previously. Despite the favorable genetic characteristics, the tumor presented poor response to complementary treatments, and rapid progression, including spinal metastasis.

Resumo

Oligodendrogliomas são tumores infiltrativos do sistema nervoso central considerados morfologicamente estáveis e com melhor prognóstico. Aqui, descrevemos o caso de um homem de 36 anos com diagnóstico inicial de oligodendroglioma grau II OMS, que apresentou transformação para uma forma sarcomatosa, mantendo as características genéticas do tumor inicial, sem ter sido submetido a tratamento complementar. Apesar das características genéticas favoráveis, o tumor apresentou má resposta aos tratamentos e progressão rápida, incluindo com metastização raquidiana.

 
  • References

  • 1 Paleologos NA, Cairncross JG. Treatment of oligodendroglioma: an update. Neuro-oncol 1999; 1 (01) 61-68
  • 2 Vajtai I, Vassella E, Hewer E, Kappeler A, Reinert MM. Sarcomatous evolution of oligodendroglioma (“oligosarcoma”): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors. Pathol Res Pract 2012; 208 (12) 750-755
  • 3 Rodriguez FJ, Scheithauer BW, Jenkins R. , et al. Gliosarcoma arising in oligodendroglial tumors (“oligosarcoma”): a clinicopathologic study. Am J Surg Pathol 2007; 31 (03) 351-362
  • 4 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. 2016. World Health Organization Histological Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer, France
  • 5 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. 2007. World Health Organization histological classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon
  • 6 Yasuda T, Nitta M, Komori T. , et al. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted. Neuropathology 2017; ••• DOI: 10.1111/ neup.12406.
  • 7 Shoji T, Saito R, Kanamori M, Sonoda Y, Watanabe M, Tominaga T. Sarcoma-like tumor originating from oligodendroglioma. Brain Tumor Pathol 2016; 33 (04) 255-260 . Doi: 10.1007/s10014-016-0268-2
  • 8 Pasquier B, Couderc P, Pasquier D, Panh MH, N'Golet A. Sarcoma arising in oligodendroglioma of the brain: a case with intramedullary and subarachnoid spinal metastases. Cancer 1978; 42 (06) 2753-2758
  • 9 Hiniker A, Hagenkord JM, Powers MP, Aghi MK, Prados MD, Perry A. Gliosarcoma arising from an oligodendroglioma (oligosarcoma). Clin Neuropathol 2013; 32 (03) 165-170
  • 10 Tanaka S, Hitotsumatsu T, Sugita Y. , et al. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses. Pathol Int 2018; 68 (10) 567-573
  • 11 Choi TM, Cheon YJ, Jung TY, Lee KH. A Stable Secondary Gliosarcoma with Extensive Systemic Metastases: A Case Report. Brain Tumor Res Treat 2016; 4 (02) 133-137